Oncology · Phase II

Top sponsors

• First People's Hospital 261 programs
• Chinese Academy of 198 programs
• George Institute for 118 programs
• United Therapeutics Europe 112 programs
• Telethon Foundation 91 programs
• Takeda 79 programs
• Regeneron UK 71 programs
• MSD Merck Sharp 63 programs
• Ningbo Cancer Hospital 62 programs
• Anaxis Pharma 57 programs
• AstraZeneca 52 programs
• HOFFMANN-LA ROCHE 50 programs

1. Olverembatinib

   The First People's Hospital of Lianyungang

   Myeloproliferative Neoplasm

   phase 2 · small molecule · active

   1 trial →

2. Olverembatinib

   Xiyuan Hospital of China Academy of Chinese Medical Sciences

   Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

   phase 2 · small molecule · completed

   1 trial →

3. OlympiaN

   AstraZeneca AB

   BRCA Mutations and Early Stage HER2-Negative Breast Cancer

   phase 2 · small molecule · active

   1 trial →

4. Omacetaxine

   Teva Pharma GmbH

   Leukemia

   phase 2 · small molecule · terminated

   2 trials →

5. Omacetaxine

   Teva Pharma GmbH

   Acute Myelogenous Leukemia (AML)

   phase 2 · small molecule · terminated

   1 trial →

6. Omacetaxine mepesuccinate

   Teva Pharma GmbH

   Chronic Myeloid Leukemia

   phase 2 · small molecule · completed

   3 trials →

7. Ommaya 02

   The First People's Hospital of Lianyungang

   Leptomeningeal Metastasis of HER2-positive Breast Cancer

   phase 2 · small molecule · active

   1 trial →

8. Omomyc

   The George Institute

   Advanced High-Grade Osteosarcoma

   phase 2 · small molecule · active

   1 trial →

9. Onapristone

   Context Therapeutics

   ER-positive Breast Cancer

   phase 2 · small molecule · terminated

   1 trial →

10. Onapristone ER

    Context Therapeutics

    Granulosa Cell Ovarian Cancer

    phase 2 · small molecule · completed

    1 trial →

11. Onvansertib

    Cardiff Oncology

    Breast Cancer

    phase 2 · small molecule · active

    1 trial →

12. Onvansertib

    Cardiff Oncology

    Acute Myeloid Leukemia

    phase 2 · small molecule · completed

    1 trial →

13. Onvansertib

    Cardiff Oncology

    Metastatic Castration-Resistant Prostate Cancer

    phase 2 · small molecule · completed

    1 trial →

14. Onvansertib

    Cardiff Oncology

    Metastatic Colorectal Cancer

    phase 2 · small molecule · active

    2 trials →

15. Onvansertib

    Cardiff Oncology

    Pancreatic Cancer

    phase 2 · small molecule · active

    1 trial →

16. Onvansertib

    Cardiff Oncology

    Pancreatic Ductal Adenocarcinoma

    phase 2 · small molecule · completed

    1 trial →

17. Onvansertib

    Cardiff Oncology

    Small-cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

18. Onvansertib

    Cardiff Oncology

    Colorectal Cancer

    phase 2 · small molecule · completed

    1 trial →

19. Oral Encochleated Amphotericin B (CAMB)

    Matinas BioPharma Holdings

    Acute Myeloid Leukemia

    phase 2 · small molecule · terminated

    1 trial →

20. Oral arsenic trioxide

    The University of Hong Kong

    Acute Myeloid Leukemia

    phase 2 · small molecule · active

    1 trial →

21. Orelabrutinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Follicular Lymphoma

    phase 2 · small molecule · active

    1 trial →

22. Orelabrutinib

    The First People's Hospital of Lianyungang

    MALT Lymphoma

    phase 2 · small molecule · active

    1 trial →

23. Orelabrutinib

    The First People's Hospital of Lianyungang

    Marginal Zone Lymphoma(MZL)

    phase 2 · small molecule · active

    1 trial →

24. Orelabrutinib

    The First People's Hospital of Lianyungang

    Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

    phase 2 · small molecule · active

    1 trial →

25. Orelabrutinib

    The First People's Hospital of Lianyungang

    Primary Central Nervous System Hodgkin Lymphoma

    phase 2 · small molecule · active

    1 trial →

26. Organoid-guided treatment

    The First People's Hospital of Lianyungang

    HER2-negative Breast Cancer

    phase 2 · small molecule · active

    1 trial →

27. Orgovyx 120 mg film-coated tablets

    Fondazione Telethon ETS

    Prostate Cancer

    phase 2 · small molecule · active

    1 trial →

28. Orteronel 300mg BID

    Takeda

    Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors

    phase 2 · small molecule · terminated

    1 trial →

29. Osimertinib + Savolitinib

    AstraZeneca

    Non-Small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

30. Osimertinib 80 mg/40 mg

    AstraZeneca

    Stage II-IIIB Non-small Cell Lung Carcinoma

    phase 2 · small molecule · active

    1 trial →

31. Oxaliplatin

    Universal Integrated

    Previously Treated Metastatic Non-Small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

32. Oxaliplatin

    Regeneron UK Limited

    Colorectal Cancer

    phase 2 · small molecule · active

    1 trial →

33. Oxaliplatin

    Sanofi Pasteur

    Uterine Neoplasms

    phase 2 · small molecule · terminated

    1 trial →

34. P276-00

    Piramal Critical Care B.V.

    Melanoma

    phase 2 · small molecule · completed

    1 trial →

35. PACLITAXEL AHCL /ml for Head and neck squamous cell carcinoma

    Ningbo Cancer Hospital

    Head and neck squamous cell carcinoma

    phase 2 · small molecule · active

    1 trial →

36. PARP inhibitor 2X-121

    Allarity Therapeutics

    Metastatic Breast Cancer

    phase 2 · small molecule · completed

    1 trial →

37. PAUF-I

    Lacuna Pharma Pty Ltd

    Advanced and/or metastatic pancreatic adenocarcinoma

    phase 2 · small molecule · active

    1 trial →

38. PAXALISIB

    KAZIA THERAPEUTICS LTD

    Primary Central Nervous System Lymphoma

    phase 2 · small molecule · active

    1 trial →

39. PBCAR20A

    Chongqing Precision Biotech Co., Ltd

    Non-Hodgkin's Lymphoma, Relapsed

    phase 2 · gene therapy · completed

    1 trial →

40. PC-IIT-003

    The First People's Hospital of Lianyungang

    Pancreatic Cancer

    phase 2 · small molecule · active

    1 trial →

41. PC14586

    PMV Pharmaceuticals

    Locally Advanced or Metastatic Solid Tumors Harboring a TP53 Y220C Mutation

    phase 2 · small molecule · active

    1 trial →

42. PCAR-019 (anti-CD19 CAR-T cells)

    The First People's Hospital of Lianyungang

    Acute Lymphocytic Leukemia

    phase 2 · mab · active

    1 trial →

43. PCS6422 and capecitabine

    Processa Pharmaceuticals

    Breast Cancer

    phase 2 · small molecule · active

    1 trial →

44. PD -1/PD-L1 monoclonal antibody plus radiotherapy and liver transplantation

    The First People's Hospital of Lianyungang

    Locally Advanced Perihilar Cholangiocarcinoma

    phase 2 · other · active

    1 trial →

45. PD 0332991

    Pfizer

    Breast Cancer

    phase 2 · small molecule · completed

    1 trial →

46. PD-1

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Rectal Cancer Patients

    phase 2 · small molecule · active

    1 trial →

47. PD-1 Inhibitor plus Chemotherapy

    Sichuan University

    Esophageal Squamous Cell Carcinoma

    phase 2 · small molecule · active

    1 trial →

48. PD-1 antibody Sintilimab

    The First People's Hospital of Lianyungang

    Multiple Primary Lung Cancers

    phase 2 · small molecule · active

    1 trial →

Frequently asked questions